Top

BMC Cancer

Published in:

Open Access 01-12-2017 | Case report

Hybrid peripheral nerve sheath tumors: report of five cases and detailed review of literature

Authors: Nasir Ud Din, Zubair Ahmad, Jamshid Abdul-Ghafar, Rashida Ahmed

Published in: BMC Cancer | Issue 1/2017

Abstract

Background

Hybrid peripheral nerve sheath tumors (PNSTs) have been recognized recently and were first included in the 4th edition of World Health Organization (WHO) Classification of Tumors of Soft tissue and Bone, published in 2013. These tumors show combined features of more than one type of conventional benign peripheral nerve sheath tumors. The most common combinations are those of schwannoma/perineurioma followed by combinations of neurofibroma/schwannoma and neurofibroma/perineurioma. A detailed literature review of published cases is presented.

We have discussed the types and etiology, epidemiology and sites of localization, gross and microscopic appearances and immunohistochemical features of hybrid PNSTs and association of these tumors with tumor syndromes.

Case presentation

We have included five cases which were diagnosed in our department as we believe that publication of these new cases is relevant for the improved understanding of these specific tumors. Four of our five patients were males, mean age was 24 years. There was wide variation in the location of these tumors. Mean size of excised tumors was 5.5 cms in the greatest dimensions. Three out of five cases represented hybrid schwannoma/perineurioma histologically. No significant nuclear atypia, mitotic activity or necrosis seen. All five cases were completely excised. All five patients are alive and well at the time of writing with no recurrence.

Conclusion

Hybrid PNSTs are distinct tumors and are usually benign. However, rare case reports have described local recurrence and at least two recent case reports have described malignant transformation in these tumors. Further studies on large number of cases are required to determine the exact pathogenetic basis of these tumors.

Hornick JL, Michal M. Hybrid nerve sheath tumors. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC; 2013.

Antonescu CR, Stemmer-Rachamimov AO, Perry A. Hybrid nerve sheath tumors. In: Louis DN, Ohgaki H, Wiestler OD, Cavenec WK, Ellison DW, et al., editors. WHO Classification of Tumors of the Central Nervous System Revised. 4th ed. IARC: Lyon; 2016. p. 224–5.

Feany MB, Anthony DC, Fletcher CD. Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge. Histopathology. 1998;32:405–10.CrossRefPubMed

Hornick JL, Bundock EA, Fletcher CD. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors. Am J Surg Pathol. 2009;33:1554–61.CrossRefPubMed

Harder A, Wesemann M, Hagel C, Schittenhelm J, Fischer S, et al. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients. Am J Surg Pathol. 2012;36:702–9.CrossRefPubMed

Evans DG, Baser ME, McGaughran J, Scharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. J Med Genet. 2002;39:311–4.CrossRefPubMedPubMedCentral

Taubenslag KJ, Nickols HH, Chelnis JG, Mawn LA. Hybrid Neurofibroma/Schwannoma of the supraorbital nerve: clinicopathologic correlation of a rare tumor. Ophthal Plast Reconstr Surg 2015;S104-S106. doi:10.1097/IOP.0000000000000597.

Michal M, Kazakov DV, Belousova I, et al. A benign neoplasm with histopathological features of both schwannoma and retiform perineurioma (benign schwannoma-perineurioma): a report of six cases of a distinctive soft tissue tumor with a predilection for the fingers. Virchows Arch. 2004;445:347–53.CrossRefPubMed

Rekhi B, Jambhekar NA. Malignant transformation in a hybrid schwannoma/perineurioma: addition to the spectrum of a malignant peripheral nerve sheath tumor. Indian J Pathol Microbiol. 2011;54:825–8.PubMed

10.

Kacerovska D, Michal M, Kuroda N, Tanaka A, Sima R, et al. Hybrid peripheral nerve sheath tumors, including a malignant variant in type 1 neurofibromatosis. Am J Dermatopathol. 2013;35:641–9.CrossRefPubMed

11.

Chow LTC. Primary intraosseous hybrid nerve sheath tumor of femur: a hitherto undescribed occurrence in bone with secondary aneurysmal bone cyst formation resulting in pathological fracture. Pathol Res Pract. 2015;211:409–14.CrossRefPubMed

12.

Yang X, Zeng Y, Wang J. Hybrid schwannoma/perineurioma: report of 10 Chinese cases supporting a distinctive entity. Int J Surg Pathol. 2013;21:22–8.CrossRefPubMed

13.

Zamecnik M. Hybrid neurofibroma/schwannoma versus schwannoma with Antoni B areas. Histopathology. 2000;36:473–4.CrossRefPubMed

14.

Kazakov DV, Pitha J, Sima R, et al. Hybrid peripheral nerve sheath tumors Schwannoma-perinoma and neurofibroma-perineurioma. A report of three cases in extradigital locations. Ann Diagn Path. 2005;9:16–23.CrossRef

15.

Murarescu ED, Ivan L, Mihailovici MS. Neurofibroma, schwannoma or a hybrid tumor of the peripheral nerve sheath? Romanian J Morphol Embryol. 2005;46:113–6.

16.

Emanuel P, Pertsemlidis DS, Gordon R, et al. Benign hybrid perineurioma-schwannoma in the colon. A case report. Ann Diagn Pathol. 2006;10:367–70.CrossRefPubMed

17.

Shelekhova KV, Danilova AB, Michal M, et al. Hybrid neurofibroma-perineurioma: an additional example of an extradigital tumor. Ann Diagn Pathol. 2008;12:233–4.CrossRefPubMed

18.

Youens KE, Woodward J, Wallace D, et al. Hybrid neurofibroma-schwannoma of the orbit. Orbit. 2008;27:223–5.CrossRefPubMed

19.

Kuroda N, Kazakov DV, Hes O, et al. Hybrid peripheral nerve sheath tumor of the nasal cavity showing schwannomatous, neurofibromatous, and perineuriomatous areas. Med Mol Morphol. 2010;43:82–5.CrossRefPubMed

20.

Hayes BD, O'Sullivan MJ. Intranodal hybrid benign nerve sheath tumor. Pediatr Dev Pathol. 2011;14:313–7.CrossRefPubMed

21.

Agaimy A, Michal M. Hybrid schwannoma-perineurioma of the gastrointestinal tract: a clinicopathologic study of 2 cases and reappraisal of perineurial cells in gastrointestinal schwannomas. Appl Immunohistochem Mol Morphol. 2011;19:454–9.CrossRefPubMed

22.

Pusiol T, Zorzi MG, Morichetti D, et al. Routine use of immunohisto-chemistry may increase the frequency of hybrid peripheral nerve sheath tumors. Am J Dermatopathol. 2011;33:634–6.CrossRefPubMed

23.

Ohata C, Imai N, Hinogami H, et al. Hybrid schwannoma/perineurioma: a report of two cases including a possible radiation-induced case. J Cutan Pathol. 2012;39:56–62.CrossRefPubMed

24.

Park JY, Park NJ, Kim SP, et al. A soft tissue perineurioma and a hybrid tumor of perineurioma and schwannoma. Korean J Pathol. 2012;46:75–8.CrossRefPubMedPubMedCentral

25.

Lang SS, Zager EL, Coyne TM, et al. Hybrid peripheral nerve sheath tumor. J Neurosurg. 2012;117:897–901.CrossRefPubMed

26.

Rodriguez FJ, Folpe AL, Giannini C, et al. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol. 2012;123:295–319.CrossRefPubMedPubMedCentral

27.

Wang L, Wang G, Gao T. Congenital melanocytic nevus with features of hybrid schwannoma/perineurioma. J Cutan Pathol. 2013;40:497–502.CrossRefPubMed

28.

Las Heras F, Martuza R, Caruso P, et al. 24-year-old woman with an internal auditory canal mass. Hybrid peripheral nerve sheath tumor with schwannoma/perineurioma components. Brain Pathol. 2013;23:361–2.CrossRefPubMed

29.

Requena L, Sitthinamsuwan P, Fried I, et al. A benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma. Am J Surg Pathol. 2013;37:845–52.CrossRefPubMed

30.

Hayashi T, Hirose T, Nishimura Y, et al. Hybrid schwannoma / perineurioma of the spinal nerve: multifocal occurrence, and recurrence as an intraneural perineurioma. Pathol Int. 2013;63:368–73.CrossRefPubMed

31.

Yamada S, Kitada S, Nabeshima A, et al. Benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma arising from the nose. Diagn Pathol. 2013;8:165.PubMedPubMedCentral

32.

Inatomi Y, Ito T, Nagae K, et al. Hybrid perineurioma-neurofibroma in a patient with neurofibromatosis type 1, clinically mimicking malignant peripheral nerve sheath tumor. Eur J Dermatol. 2014;24:412–3.PubMed

33.

Soria-Cespedes D, Robles-Vidal C, Gomez-Gonzalez A, et al. Primary pleural hybrid cellular schwannoma/perineurioma: a case report. Respir Investig. 2014;52:269–73.CrossRefPubMed

34.

Murray S, Bullock MJ, Taylor SM. A case of multiple neurofibroma/schwannoma hybrid tumors of the facial nerve. Otolaryngol Head Neck Surg. 2015;152:569–70.CrossRefPubMed

35.

Linos K, Stuart L, Goncharuk V, et al. Benign cutaneous biphasic hybrid tumor of perineurioma and cellular neurothekeoma: A case report expanding the clinical and histopathologic features of a recently described entity. Am J Dermatopathol. 2015;37:319–22.CrossRefPubMed

36.

Panda KM, Reena N. Intraneural Hybrid Neurofibroma/Schwannoma in scalp: a case report. J Clin Diagn Res. 2015;9:5–6.

37.

McLaughlin CT, Kaffenberger BH, Gru AA. A hybrid tumor with schwannoma-perineurioma-neurofibroma morphology. J Cutan Pathol. 2015;42:911–3.CrossRefPubMed

38.

Stahn V, Nagel I, Fischer-Huchzermeyer S, Oyen F, Schneppenheim R, et al. Molecular analysis of hybrid Neurofibroma/Schwannoma identifies common monosomy 22 and α-T- Catenin/CTNNA3 as a novel candidate tumor suppressor. Am J Pathol. 2016;186:3285–96.CrossRefPubMed

Title: Hybrid peripheral nerve sheath tumors: report of five cases and detailed review of literature
Authors: Nasir Ud Din
Zubair Ahmad
Jamshid Abdul-Ghafar
Rashida Ahmed
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-017-3350-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2017

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604

A metastatic invasive mole arising from iatrogenic uterus perforation

Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer